Biopharma Thought Leadership Blog | AGC Biologics

Flexible, Scalable Biologics Manufacturing for Clinical and Commercial Programs

Written by AGC Biologics | July 16, 2026 at 8:06 PM

Here's what you'll learn from our experts featured in this blog post: 

  • How AGC Biologics single-use manufacturing solutions deliver the reliability and flexibility your program demands

  • Why our flexible process development approach is purpose-built for complex, atypical molecules that don't fit the standard mold

  • How AGC Biologics optimizes production for complex proteins, including bispecifics and other non-standard biologics

  • The proven microbial fermentation feeding strategies that ensure consistent, scalable expression from lab to commercial scale

  • AGC Biologics perfusion manufacturing processes enabling high-yield, continuous bioprocessing for your most demanding programs

We believe that great science deserves a manufacturing partner that truly understands your molecule, your goals, and your urgency. That's why we're giving you direct insights from the scientists and engineers who make it happen every day working across our Seattle and Copenhagen facilities. 

Whether you're a biotech founder racing toward your first IND filing, a VP of CMC managing a complex late-stage pipeline, or a procurement leader evaluating CDMO partners for long-term commercial supply, these videos answer common questions we address on a daily basis to help you make the right decision when selecting your next outsourcing partner.


Click below to watch each video